Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Response”

Showing 20 of 0 results

Not applicableStudy completedNCT01506843
What this trial is testing

Sublingual Immunotherapy in Children With Allergic Rhinitis

Who this might be right for
Allergic Rhinitis
Federal University of Uberlandia 122
Early research (Phase 1)Study completedNCT01545349
What this trial is testing

Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine

Who this might be right for
HealthyInfluenza
Patricia L. Hibberd 30
Testing effectiveness (Phase 2)Study completedNCT02202395
What this trial is testing

Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Shanghai Pharmaceuticals Holding Co., Ltd 120
Testing effectiveness (Phase 2)Study completedNCT00394654
What this trial is testing

Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma

Who this might be right for
Asthma
MedImmune LLC 30
Not applicableStudy completedNCT03013322
What this trial is testing

Anticholium® Per Se

Who this might be right for
Shock, SepticSepsisPerioperative Period
University Hospital Heidelberg 20
Testing effectiveness (Phase 2)Study completedNCT00504595
What this trial is testing

Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Novartis 80
Testing effectiveness (Phase 2)Study completedNCT03562377
What this trial is testing

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Who this might be right for
Atopic Dermatitis
LEO Pharma 215
Testing effectiveness (Phase 2)Ended earlyNCT00348439
What this trial is testing

Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment

Who this might be right for
Vitreoretinal Traction Syndrome
Bausch & Lomb Incorporated 29
Not applicableStudy completedNCT02802241
What this trial is testing

Effects of Open-label vs Double-blind Treatment in IBS

Who this might be right for
Irritable Bowel SyndromePlacebo EffectPlacebos+1 more
Beth Israel Deaconess Medical Center 340
Large-scale testing (Phase 3)Study completedNCT00192231
What this trial is testing

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)

Who this might be right for
Influenza
MedImmune LLC 120
Testing effectiveness (Phase 2)Study completedNCT05507437
What this trial is testing

Pharmacokinetics and Safety of TIN816 in Patients With Sepsis-associated Acute Kidney Injury

Who this might be right for
Acute Kidney Injury Due to Sepsis
Novartis Pharmaceuticals 20
Early research (Phase 1)Study completedNCT01053650
What this trial is testing

Placebo Effect of Paracetamol in Healthy Volunteers

Who this might be right for
Healthy Volunteers
University Hospital, Clermont-Ferrand 40
Large-scale testing (Phase 3)Study completedNCT00886600
What this trial is testing

Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)

Who this might be right for
Hypertension
Merck Sharp & Dohme LLC 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07436611
What this trial is testing

Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

Who this might be right for
Port Wine Stains
AFT Pharmaceuticals, Ltd. 30
Not applicableLooking for participantsNCT07622628
What this trial is testing

AIM-MET: AI-Guided Microbiome-Targeted Nutrition for Glycemic Improvement in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetes Mellitus Type 2
ENBIOSIS BIOTECHNOLOGIES 100
Large-scale testing (Phase 3)Study completedNCT03826628
What this trial is testing

Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex

Who this might be right for
Facial AngiofibromaTuberous Sclerosis
Dermatology Specialties Limited Partnership 107
Large-scale testing (Phase 3)Active Not RecruitingNCT04526665
What this trial is testing

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Who this might be right for
Primary Biliary Cirrhosis
Ipsen 161
Testing effectiveness (Phase 2)Study completedNCT02834507
What this trial is testing

Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 19
Testing effectiveness (Phase 2)Study completedNCT00134693
What this trial is testing

A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 77
Testing effectiveness (Phase 2)Study completedNCT01500200
What this trial is testing

Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 142
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation